Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia

Serum zinc (Zn) levels tend to be low in chronic kidney disease (CKD) patients. This cohort study was conducted to investigate the relationship between zinc deficiency and CKD progression. Patients were classified into two groups based on Zn levels < 60 μg/dl (low-Zn group, n = 160) and ≥ 60 μg/dl (high-Zn group, n = 152). The primary outcome was defined as end-stage kidney disease (ESKD) or death and was examined over a 1-year observation period. Overall, the mean Zn level was 59.6 μg/dl and the median eGFR was 20.3 ml/min/1.73 m2. The incidence of the primary outcome was higher in the low-Zn group (p<0.001). Various Cox proportional hazards models adjusted for baseline characteristics showed higher risks of the primary outcome in the low-Zn group than in the high-Zn group. Competing risks analysis showed that low Zn levels were associated with ESKD but not with death. Moreover, in propensity score-matched analysis, the low-Zn group showed a higher risk of the primary outcome [adjusted hazard ratio 1.81 (95% confidence interval 1.02, 3.24)]. Furthermore, an interaction was observed between Zn and serum albumin levels (interaction p = 0.026). The results of this study indicate that zinc deficiency is a risk factor for CKD progression.

[1]  Jean-Pierre Ghobril,et al.  Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  J. Wetzels,et al.  The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseases. , 2019, Kidney international.

[3]  Zuyi Yuan,et al.  Zinc supplementation protects against diabetic endothelial dysfunction via GTP cyclohydrolase 1 restoration. , 2019, Biochemical and biophysical research communications.

[4]  D. Kang,et al.  Association between Dietary Mineral Intake and Chronic Kidney Disease: The Health Examinees (HEXA) Study , 2018, International journal of environmental research and public health.

[5]  T. Kawaguchi,et al.  The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease , 2018, Journal of clinical medicine research.

[6]  Xiuli Zhang,et al.  Effect of zinc deficiency on mouse renal interstitial fibrosis in diabetic nephropathy. , 2016, Molecular medicine reports.

[7]  A. Go,et al.  Inflammation and Progression of CKD: The CRIC Study. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[8]  Y. Ohashi,et al.  Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study , 2016, Clinical and Experimental Nephrology.

[9]  A. Makhlough,et al.  Comparing the Levels of Trace Elements in Patients With Diabetic Nephropathy and Healthy Individuals , 2015, Nephro-urology monthly.

[10]  T. Kambe,et al.  Current understanding of ZIP and ZnT zinc transporters in human health and diseases , 2014, Cellular and Molecular Life Sciences.

[11]  Yang V. Li,et al.  Zinc and insulin in pancreatic beta-cells , 2014, Endocrine.

[12]  P. Sadler,et al.  Allosteric modulation of zinc speciation by fatty acids. , 2013, Biochimica et biophysica acta.

[13]  J. King Zinc: an essential but elusive nutrient. , 2011, The American journal of clinical nutrition.

[14]  T. Hirano,et al.  Zinc homeostasis and signaling in health and diseases , 2011, JBIC Journal of Biological Inorganic Chemistry.

[15]  N. Kashihara,et al.  Oxidative stress in diabetic nephropathy. , 2010, Current medicinal chemistry.

[16]  Jie Chen,et al.  Roles of zinc and copper in modulating the oxidative refolding of bovine copper, zinc superoxide dismutase. , 2010, Acta biochimica et biophysica Sinica.

[17]  Jian Xiao,et al.  Zinc supplementation partially prevents renal pathological changes in diabetic rats. , 2010, The Journal of nutritional biochemistry.

[18]  N. Kashihara,et al.  Zinc Deficiency Anemia and Effects of Zinc Therapy in Maintenance Hemodialysis Patients , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[19]  J. Danesh,et al.  Renal Function and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Systematic Review , 2007, PLoS medicine.

[20]  T. Hibi,et al.  Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation of TIMP‐1: A pilot study , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[21]  W. Maret,et al.  Zinc requirements and the risks and benefits of zinc supplementation. , 2006, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[22]  Tohru Kimura,et al.  Differential effects of GATA-1 on proliferation and differentiation of erythroid lineage cells. , 2006, Blood.

[23]  N. Komai,et al.  NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. , 2005, American journal of physiology. Renal physiology.

[24]  Bin Bao,et al.  Antioxidant effect of zinc in humans. , 2004, Free radical biology & medicine.

[25]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[26]  J. King,et al.  Effect of acute zinc depletion on zinc homeostasis and plasma zinc kinetics in men. , 2001, The American journal of clinical nutrition.

[27]  R. Huber,et al.  Zinc plays a key role in human and bacterial GTP cyclohydrolase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Goessler,et al.  Role of Bound Zinc in Dimer Stabilization but Not Enzyme Activity of Neuronal Nitric-oxide Synthase* , 2000, The Journal of Biological Chemistry.

[29]  C. Fierke,et al.  Function and mechanism of zinc metalloenzymes. , 2000, The Journal of nutrition.

[30]  K. Biersack,et al.  Factors underlying abnormal zinc metabolism in uremia. , 1989, Kidney international. Supplement.

[31]  R. Hoover,et al.  NADPH oxidase-2 mediates zinc deficiency-induced oxidative stress and kidney damage. , 2017, American journal of physiology. Cell physiology.

[32]  K. Channon,et al.  Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice , 2016, Laboratory Investigation.

[33]  M. Tonelli,et al.  Trace elements in hemodialysis patients: A systematic review , 2009 .

[34]  M. Amini,et al.  Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. , 2008, The review of diabetic studies : RDS.